Epigenetic profiling for prognostic stratification and personalized therapy in breast cancer.

Journal: Frontiers in immunology
PMID: 39877345

Abstract

BACKGROUND: The rising incidence of breast cancer and its heterogeneity necessitate precise tools for predicting patient prognosis and tailoring personalized treatments. Epigenetic changes play a critical role in breast cancer progression and therapy responses, providing a foundation for prognostic model development.

Authors

  • Xiao Guo
    School of Pharmacy, Beihua University, Jilin, China.
  • Chuanbo Feng
    School of Pharmacy, Beihua University, Jilin, China.
  • Jiaying Xing
    School of Pharmacy, Beihua University, Jilin, China.
  • Yuyan Cao
    School of Pharmacy, Beihua University, Jilin, China.
  • Tengda Liu
    School of Pharmacy, Beihua University, Jilin, China.
  • Wenchuang Yang
    School of Pharmacy, Beihua University, Jilin, China.
  • Runhong Mu
    School of Basic Medical Sciences, Beihua University, Jilin, China.
  • Tao Wang
    Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Keywords

External Resources

Popular Topics
Recent Journals